Capital International Investors Amgen Inc Transaction History
Capital International Investors
- $557 Billion
- Q2 2025
A detailed history of Capital International Investors transactions in Amgen Inc stock. As of the latest transaction made, Capital International Investors holds 18,910,776 shares of AMGN stock, worth $5.39 Billion. This represents 0.95% of its overall portfolio holdings.
Number of Shares
18,910,776
Previous 15,134,865
24.95%
Holding current value
$5.39 Billion
Previous $4.72 Billion
11.98%
% of portfolio
0.95%
Previous 0.97%
Shares
31 transactions
Others Institutions Holding AMGN
# of Institutions
3,271Shares Held
445MCall Options Held
7.23MPut Options Held
6.71M-
Vanguard Group Inc Valley Forge, PA53.7MShares$15.3 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY46MShares$13.1 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.2MShares$8.32 Billion0.38% of portfolio
-
Capital World Investors Los Angeles, CA16.9MShares$4.8 Billion0.71% of portfolio
-
Morgan Stanley New York, NY16.2MShares$4.63 Billion0.37% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $152B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...